Annovis Bio (ANVS) Payables (2019 - 2026)
Annovis Bio (ANVS) posted Payables of $3.33 million for Q2 2026, up 241.5% from $974,311 a year earlier but down 36.9% from the prior quarter.
Powered by 
Analysis
Annovis Bio (ANVS) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Annovis Bio's Payables came in at $2.59 million, up 12.3% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of 49.9% (FY2020 to FY2025).
- In prior years, Annovis Bio's Payables was $2.31 million in FY2024 (+78.4%), $1.29 million in FY2023 (-67.4%), $3.96 million in FY2022 (+475.7%) and $688,074 in FY2021 (+101.3%).
- Quarterly Payables has run from a low of $289,742 in Q3 2021 to a high of $5.28 million in Q1 2026 over five years.
- On a year-over-year basis, Payables has increased in each of the last three quarters, with growth averaging 68.0% over the last eight quarters.
- The strongest year-over-year quarter for Payables in the past five years was Q2 2022, with growth of 685.4%; the weakest was Q2 2025, with a decline of 71.3%.
- According to Business Quant data, Payables for the three prior quarters was $5.28 million (Q1 2026), $2.59 million (Q4 2025) and $2.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Annovis Bio | 37.22 Mn | -30.56 Mn | - | 3.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.33 Mn |
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 2.59 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 974,311.00 |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 2.31 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | 4.11 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 4.15 Mn |
| Dec 31, 2022 | 3.96 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 901,841.00 |
| Mar 31, 2022 | 928,997.00 |
| Dec 31, 2021 | 688,074.00 |
| Sep 30, 2021 | 289,742.00 |
API Access
Annovis Bio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();